Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Cost-effectiveness analysis of a multiplex lateral flow rapid diagnostic test for acute non-malarial febrile illness in rural Cambodia and Bangladesh.

Chew R. et al, (2024), Lancet Reg Health Southeast Asia, 23

A systematic literature review of economic evaluation studies of interventions impacting antimicrobial resistance.

Painter C. et al, (2023), Antimicrobial resistance and infection control, 12

Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic.

Wang Y. et al, (2023), The European journal of health economics : HEPAC : health economics in prevention and care, 24, 735 - 748

How to model the impact of vaccines for policymaking when the characteristics are uncertain: A case study in Thailand prior to the vaccine rollout during the COVID-19 pandemic.

Luangasanatip N. et al, (2023), Vaccine, 41, 4854 - 4860

A model-based study to estimate the health and economic impact of health technology assessment in Thailand.

Kingkaew P. et al, (2022), International journal of technology assessment in health care, 38

A protocol for a systematic literature review of economic evaluation studies of interventions to address antimicrobial resistance.

Ananthakrishnan A. et al, (2021), Systematic reviews, 10

Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making.

Teerawattananon Y. et al, (2021), Cost effectiveness and resource allocation : C/E, 19

Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines.

Painter C. et al, (2021), Applied health economics and health policy, 19, 463 - 472

Hepatitis C prevalences in the psychiatric setting: Cost-effectiveness of scaling-up screening and direct-acting antiviral therapy.

Girardin F. et al, (2021), JHEP reports : innovation in hepatology, 3

Research collaboration is needed to inform quarantine policies for health-care workers.

Kc S. et al, (2021), Lancet (London, England), 397

Assessing fitness-for-purpose and comparing the suitability of COVID-19 multi-country models for local contexts and users

Clapham H. et al, (2021)

A Protocol for a Systematic Literature Review of Economic Evaluation Studies of Interventions to Address Antimicrobial Resistance

Ananthakrishnan A. et al, (2020)

Hepatitis C virus screening of people with severe mental illness: a cost-effectiveness analysis

Girardin F. et al, (2020), JOURNAL OF HEPATOLOGY, 73, S818 - S819

Include forthcoming?